Financial Consulate »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Financial Consulate

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Financial Consulate from 13F filings

Historical chart of Financial Consulate investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Financial Consulate consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Financial Consulate

Quarter filed Position value Share count Share price at filing
2026-03-31 $920k 999k 0.92

More positions owned by Financial Consulate

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Dimensional Etf Trust Us High Profitab (DUHP)
Pimco Equity Ser Rafi Dyn Multi (MFDX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Dimensional Etf Trust Intl High Profit (DIHP)
Ishares Tr Trust Ishare 0-1 (SHV)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Schwab Strategic Tr Fundamental Us B (FNDB)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Apple (AAPL)
Pgim Etf Tr Pgim Ultra Sh Bd (PULS)
Schwab Strategic Tr Fundamental Emer (FNDE)
T Rowe Price Etf Cap Appreciation (TCAF)

View all positions for Financial Consulate

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Jpmorgan Chase & Co
Highbridge Capital Management
DG Capital Management
D. E. Shaw & Co
LMR Partners
Calamos Advisors
Corbyn Investment Management
Bnp Paribas Investment Partners
State of Wisconsin Investment Board
Palisade Capital Management
FMR
Advent Capital Management
Financial Consulate
Morgan Stanley
HB Wealth Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1